Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Immunologic Research
|
May 23, 2002
Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion
Gordon D Ross
Current Protocols in Immunology
|
April 25, 2008
Isolation and purification of C3 from human plasma
Lynda D O'Rear, Gordon D Ross
Current Protocols in Immunology
|
April 25, 2008
Assays for membrane complement receptors
Lynda D O'Rear, Gordon D Ross
Trends in Immunology
|
March 24, 2004
Complement function in mAb-mediated cancer immunotherapy
Kyra A Gelderman, Stephen Tomlinson, Gordon D Ross, et al.
Folia Histochemica Et Cytobiologica
|
June 29, 2007
Oral beta-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice
Jarek Baran, Daniel J Allendorf, Feng Hong, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2002
Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion
Yu Xia, Gita Borland, Jibiao Huang, et al.
Cancer Research
|
December 26, 2003
Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells
Feng Hong, Richard D Hansen, Jun Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2005
C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan
Daniel J Allendorf, Jun Yan, Gordon D Ross, et al.
Blood
|
November 8, 2003
Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow
Janina Ratajczak, Ryan Reca, Magda Kucia, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 9, 2004
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models
Feng Hong, Jun Yan, Jarek T Baran, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Immunologic Research
|
May 23, 2002
Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion
Gordon D Ross
Current Protocols in Immunology
|
April 25, 2008
Isolation and purification of C3 from human plasma
Lynda D O'Rear, Gordon D Ross
Current Protocols in Immunology
|
April 25, 2008
Assays for membrane complement receptors
Lynda D O'Rear, Gordon D Ross
Trends in Immunology
|
March 24, 2004
Complement function in mAb-mediated cancer immunotherapy
Kyra A Gelderman, Stephen Tomlinson, Gordon D Ross, et al.
Folia Histochemica Et Cytobiologica
|
June 29, 2007
Oral beta-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice
Jarek Baran, Daniel J Allendorf, Feng Hong, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 22, 2002
Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion
Yu Xia, Gita Borland, Jibiao Huang, et al.
Cancer Research
|
December 26, 2003
Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells
Feng Hong, Richard D Hansen, Jun Yan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 21, 2005
C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan
Daniel J Allendorf, Jun Yan, Gordon D Ross, et al.
Blood
|
November 8, 2003
Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow
Janina Ratajczak, Ryan Reca, Magda Kucia, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 9, 2004
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models
Feng Hong, Jun Yan, Jarek T Baran, et al.
Page
of 1